April 2, 2025
Danish-founded biotech company Pila Pharma looks to secure a partnership
The Danish-founded biotech company Pila Pharma said Wednesday in a press release it looks to secure a partnership or acquisition…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
March 14, 2025
European Commission approves Bristol Myers Squibb’s Breyanzi for Relapsed or Refractory Follicular Lymphoma
The European Commission (EC) has granted approval to Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy, Bristol Myers Squibb said Friday.
March 12, 2025
CordenPharma & Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables & Oral Formulations
CordenPharma, a leading Contract Development & Manufacturing Organization (CDMO) specializing in the supply of peptide APIs and peptide-based therapeutic finished dosage drug products, is pleased to announce the signing of a strategic partnership with Viking Therapeutics, a clinical stage company focused on developing novel therapies for metabolic and endocrine disorders.
March 3, 2025
New study confirms prebiotic efficacy of Clasado’s Bimuno GOS at ultra-low dose of just 380mg
Clasado Biosciences, a developer of prebiotic ingredients and products for the gut microbiome, has announced its Bimuno GOS shows a…
March 2, 2025
Valneva’s IXCHIQ could become the first vaccine against the chikungunya virus (CHIKV) available in the EU
Valneva SE, a specialty vaccine company, said on Friday that the Committee for Medicinal Products for Human Use (CHMP) of…
February 14, 2025
Moderna reports full-year revenues of $3.2 billion, down from $6.8 in 2023 as Covid-19 vax sales drops
Moderna reports full-year revenues of $3.2 billion, GAAP net loss of $(3.6) billion and GAAP diluted EPS of $(9.28), and expects 2025 revenue range of $1.5 to 2.5 billion andending cash balance of approximately $6 billion.
February 13, 2025
Barentz appoints new CFO
Barentz, a leading global specialty ingredients solution provider, has appointed Esther Veninga as Chief Financial Officer (CFO) and as a member of the Board.
February 13, 2025
JuliaHub doubling investment in the pharmaceutical sector
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform. The company said…
February 13, 2025
Lindis grants Pharmanovia rights to market and spearhead its launch across Europe
Lindis Biotech GmbH, a clinical stage biopharmaceutical company, and Pharmanovia, a global pharmaceutical company, announced Thursday that catumaxomab has received marketing authorisation from the European Commission (EC), making the drug the only approved drug therapy for malignant ascites (MA) for patients living with this debilitating condition across Europe.
February 12, 2025
Axplora announces €50 million investment in its Mourenx site, France
Axplora, a global leader in API small molecule and ADC manufacturing, has announced a landmark €50 million investment in its Mourenx site in Southwest France, securing its position as a key player in the fight against cardiovascular and metabolic diseases.